- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|XC-302 | XC302|
|Puquitinib is an orally active, PI3 kinase inhibitor that induces autophagy by inhibiting the PI3K/AKT/mTOR signaling pathway. Puquitinib is selective for p110δ relative to other PI3K class I enzymes. It is a clinical lead developed for antitumour activity .
Puquitinib is a 'pseudo' INN, that takes the form of an INN, but has not been submitted to the World Health Organisation for ratification.
|GtoPdb PubChem SID||363894222|
|Search Google for chemical match using the InChIKey||QUTFBURLXCODBH-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||QUTFBURLXCODBH|
|Search UniChem for chemical match using the InChIKey||QUTFBURLXCODBH-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||QUTFBURLXCODBH|